Article
Evaluation of a new-generation line-probe assay that detects 5' untranslated and core regions to genotype and subtype hepatitis C virus.
American journal of clinical pathology - 1 Aug 2007
Nadarajah Rohan, Khan G Yasmeen, Miller Steven A, Brooks Geo F
Abstract excerpt
The VERSANT HCV Genotype 2.0 Assay (LiPA 2.0; Innogenetics, Ghent, Belgium; distributed by Siemens Medical Solutions Diagnostics, Tarrytown, NY) is a new-generation line-probe assay that simultaneously detects sequences in the 5' untranslated (5'UTR) and core regions to genotype and subtype hepatitis C virus (HCV). We tested 60 specimens of known genotype and subtype and 2 specimens with mixed infections with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
